1-5 of 5
Xinghui Tian
Close
Sort by
Journal Articles

Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity

Petter S. Woll, Bartosz Grzywacz, Xinghui Tian, Rebecca K. Marcus, David A. Knorr, Michael R. Verneris, Dan S. Kaufman
Journal: Blood
Blood (2009) 113 (24): 6094–6101.
https://doi.org/10.1182/blood-2008-06-165225
Published: 2009
Includes: Supplemental data
Journal Articles

Human Embryonic Stem Cell-Derived CD34+ Cells Preferentially Develop into Endothelial Cells When Transplanted into Neonatal Immunodeficient Mice

Xinghui Tian, PhD, Melinda K. Hexum, Vesselin R. Penchev, Russell J. Taylor, Leonard Shultz, PhD, Dan S. Kaufman, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 69.
https://doi.org/10.1182/blood.V112.11.69.69
Published: 2008
Journal Articles

Human embryonic stem cell–derived hematopoietic cells are capable of engrafting primary as well as secondary fetal sheep recipients

A. Daisy Narayan, Jessica L. Chase, Rachel L. Lewis, Xinghui Tian, Dan S. Kaufman, James A. Thomson, Esmail D. Zanjani
Journal: Blood
Blood (2006) 107 (5): 2180–2183.
https://doi.org/10.1182/blood-2005-05-1922
Published: 2006
Includes: Supplemental data
Journal Articles

Improved Analysis of Hematopoietic Engraftment by Non-Invasive In Vivo Bioluminescent Imaging of Transplanted Human Embryonic Stem Cell-Derived Hematopoietic Cells.

Jonathan L. Linehan, BS, Xinghui Tian, PhD, Julie K. Morris, BS, Dan S. Kaufman, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 1270.
https://doi.org/10.1182/blood.V106.11.1270.1270
Published: 2005
Journal Articles

CD34+ Cells Derived from Human Embryonic Stem Cells Demonstrate Hematopoietic Stem Cell Potential In Vitro and in Vivo.

Dan S. Kaufman, MD, PhD, Petter S. Woll, MS, Colin H. Martin, PhD, Jon L. Linehan, BS, Xinghui Tian, PhD
Journal: Blood
Blood (2004) 104 (11): 564.
https://doi.org/10.1182/blood.V104.11.564.564
Published: 2004